Intrinsic Value of S&P & Nasdaq Contact Us

InnovaQor, Inc. VMCS OTC

Other OTC • Healthcare • Medical - Healthcare Information Services • US • USD

SharesGrow Score
10/100
0/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

InnovaQor, Inc. (VMCS) generated $-2.05M in operating cash flow for fiscal year 2022. After capital expenditures of $0.00, free cash flow was $-2.05M.

Free cash flow margin was -596.5% of revenue. Cash conversion ratio was 1x, indicating earnings are backed by cash.

Criteria supported by this page:

  • HEALTH (0/100, Fail) — weak cash flow raises concerns about debt servicing
  • MOAT (0/100, Fail) — limited free cash flow weakens the competitive position
  • INCOME (10/100) — Cash conversion ratio was 1x confirms earnings are backed by real cash flow

Overall SharesGrow Score: 9/100 with 0/7 criteria passed.

SharesGrow 7-Criteria Score
10/100
SG Score
View full scorecard →
VALUE
N/A
No coverage
FUTURE
N/A
No coverage
PAST
0/100
→ Income
HEALTH
0/100
Debt-to-Equity & liquidity
Proven by this page
MOAT
0/100
Proven by this page
~
GROWTH
40/100
→ Income
INCOME
10/100
→ Income
InnovaQor, Inc. Cash Flow History
Metric TTM FY2022 FY2007 FY2006 FY2005
Operating Cash Flow $494.57K$-2.05M$228.11K$-2.08M$-1.95M
Capital Expenditure $11.58K$0.00$-13.18K$-54.27K$-25.52K
Free Cash Flow $506.14K$-2.05M$214.93K$-2.13M$-1.97M
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message